Page 41 - Global Growth Pharmaceuticals & Biotech Stocks

UPDATED Sep 09, 2025

Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

3,050 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
JSPR
Jasper Therapeutics
US$2.59-6.2%-87.2%US$42.1mUS$19.63PB1.8xE2.5%n/a
603259
WuXi AppTec
CN¥106.37-5.0%185.3%CN¥310.9bCN¥114.20PE19.8xE2.4%0.9%
600216
Zhejiang Medicine
CN¥15.23-1.3%6.1%CN¥14.6bCN¥18.25PE9.6xE2.2%2.4%
MNOV
MediciNova
US$1.28-2.3%-34.7%US$62.8mUS$7.00PS466.4xE2.2%n/a
INCY
Incyte
US$85.60-0.4%35.6%US$16.7bUS$80.73PE19.2xE1.8%n/a
2696
Shanghai Henlius Biotech
HK$85.9011.6%271.1%HK$46.7bHK$95.84PE51.8xE1.8%n/a
TYRA
Tyra Biosciences
US$11.82-5.7%-44.9%US$630.0mUS$30.75PB2.1xE1.7%n/a
NKTX
Nkarta
US$2.07-1.4%-68.2%US$147.0mUS$12.40PB0.4xE1.7%n/a
IMRX
Immuneering
US$7.0517.7%490.0%US$293.1mUS$12.80PB10.1xE1.6%n/a
DNTH
Dianthus Therapeutics
US$35.5749.1%27.9%US$1.1bUS$59.23PS235.9xE1.5%n/a
XNCR
Xencor
US$8.31-2.8%-56.6%US$592.7mUS$24.10PS4xE1.5%n/a
PFIZER
Pfizer
₹5,153.000.9%-15.9%₹235.7b₹6,483.33PE29.2xE1.3%0.7%
PLRX
Pliant Therapeutics
US$1.754.5%-86.5%US$107.4mUS$3.17PB0.5xE1.3%n/a
4886
ASKA Pharmaceutical HoldingsLtd
JP¥2,445.00-3.7%10.8%JP¥69.3bJP¥2,550.00PE13.7xE1.3%2.2%
EPRX
Eupraxia Pharmaceuticals
CA$7.33-2.3%118.8%CA$263.6mCA$12.50PE-6.5xE1.1%n/a
TCRX
TScan Therapeutics
US$1.845.1%-68.9%US$104.4mUS$8.57PS15xE1.1%n/a
A006280
GC Biopharma
₩132,600.002.9%-16.5%₩1.5t₩196,500.00PE20.5xE1.1%1.1%
VVY
Vivoryon Therapeutics
€1.66-1.3%-13.3%€43.4m€8.60PB13.7xE0.9%n/a
NXTC
NextCure
US$5.072.8%-68.7%US$13.6mUS$17.50PB0.5xE0.9%n/a
1795
Lotus Pharmaceutical
NT$192.50-0.3%-30.8%NT$50.6bNT$322.40PE10.4xE0.8%3.0%
4507
Shionogi
JP¥2,680.504.7%24.2%JP¥2.3tJP¥2,535.00PE12.7xE0.6%2.5%
HVO
hVIVO
UK£0.098-3.4%-66.8%UK£66.7mn/aPE6.3xE0.6%2.0%
CDTX
Cidara Therapeutics
US$62.96-1.3%426.9%US$1.6bUS$79.80PB3.2xE0.6%n/a
PRME
Prime Medicine
US$4.1232.1%3.0%US$540.1mUS$6.89PS108.9xE0.4%n/a
Page 41 of 128